Michael T. Jaklitsch
Impact in
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Diagnosis and Treatment
- Pleural and Pulmonary Diseases
- Occupational and environmental lung diseases
- Lung Cancer Treatments and Mutations
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Medical Imaging and Pathology Studies
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lung Cancer Diagnosis and Treatment 97
- Lung Cancer Treatments and Mutations 49
- Pleural and Pulmonary Diseases 47
- Occupational and environmental lung diseases 29
- Gastric Cancer Management and Outcomes 18
- Tracheal and airway disorders 14
- Surgery 76
- Esophageal Cancer Research and Treatment 31
- Esophageal and GI Pathology 19
- Co-authors
- David J. Sugarbaker (63 shared papers)Raphael Bueno (61 shared papers)Steven J. Mentzer (27 shared papers)Steven Swanson (34 shared papers)Jeanne M. Lukanich (17 shared papers)William G. Richards (18 shared papers)Raphael Bueno (21 shared papers)Yolonda L. Colson (14 shared papers)
- Journals
- The Annals of Thoracic Surgery (30 papers)Journal of Thoracic and Cardiovascular Surgery (22 papers)Journal of Surgical Oncology (17 papers)CHEST Journal (13 papers)Journal of Clinical Oncology (11 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Michael T. Jaklitsch
190 papers receiving 9.1k citations
Michael T. Jaklitsch's Hit Papers
Peers
Comparison fields: 5 of 141
- Pulmonary and Respiratory Medicine 5.6k
- Oncology 2.5k
- Microbiology 59
- Immunology 1.3k
- Otorhinolaryngology 243
Countries citing papers authored by Michael T. Jaklitsch
This map shows the geographic impact of Michael T. Jaklitsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael T. Jaklitsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael T. Jaklitsch more than expected).
Fields of papers citing papers by Michael T. Jaklitsch
This network shows the impact of papers produced by Michael T. Jaklitsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael T. Jaklitsch. The network helps show where Michael T. Jaklitsch may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael T. Jaklitsch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 204 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients Hit paper breakdown → | 2003 | 778 |
| 2 | Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients Hit paper breakdown → | 1999 | 697 |
| 3 | Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Hit paper breakdown → | 1994 | 500 |
| 4 | Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients Hit paper breakdown → | 2008 | 488 |
| 5 | The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups Hit paper breakdown → | 2012 | 464 |
| 6 | 2004 | 268 | |
| 7 | 1994 | 240 | |
| 8 | 2005 | 238 | |
| 9 | 2003 | 225 | |
| 10 | 2000 | 192 | |
| 11 | 2006 | 167 | |
| 12 | 2001 | 159 | |
| 13 | 2014 | 155 | |
| 14 | 2005 | 146 | |
| 15 | 2011 | 142 | |
| 16 | 2003 | 142 | |
| 17 | 2004 | 133 | |
| 18 | 1992 | 125 | |
| 19 | 2014 | 124 | |
| 20 | 2009 | 122 |
About Michael T. Jaklitsch
Michael T. Jaklitsch is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Radiology, Nuclear Medicine and Imaging and Cardiology and Cardiovascular Medicine, having authored 204 papers that have together received 9.3k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (97 papers), Lung Cancer Treatments and Mutations (49 papers), Pleural and Pulmonary Diseases (47 papers), Esophageal Cancer Research and Treatment (31 papers), Occupational and environmental lung diseases (29 papers), Esophageal and GI Pathology (19 papers), Gastric Cancer Management and Outcomes (18 papers) and Tracheal and airway disorders (14 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (5.6k citations), Oncology (2.5k citations), Microbiology (59 citations), Immunology (1.3k citations) and Otorhinolaryngology (243 citations). Michael T. Jaklitsch has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include David J. Sugarbaker, Raphael Bueno, Steven J. Mentzer, Steven Swanson, Jeanne M. Lukanich, William G. Richards, Raphael Bueno, Yolonda L. Colson, Magang Shou and Ellis F. Unger. Their work appears in journals such as The Annals of Thoracic Surgery, Journal of Thoracic and Cardiovascular Surgery, Journal of Surgical Oncology, CHEST Journal and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.